Global Pandemic Influenza Vaccine Market Insights, Forecast to 2025

Publisher Name :
Date: 24-May-2019
No. of pages: 111
Inquire Before Buying

Influenza vaccines treat influenza by developing antibodies in the body within two weeks after vaccination. These antibodies protect against infections with the help of the attenuated viruses in the vaccine. These vaccines contain killed or inactivated strains of the influenza virus.

The global Pandemic Influenza Vaccine market is valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Pandemic Influenza Vaccine market based on company, product type, end user and key regions.

This report studies the global market size of Pandemic Influenza Vaccine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Pandemic Influenza Vaccine in these regions.

This research report categorizes the global Pandemic Influenza Vaccine market by top players/brands, region, type and end user. This report also studies the global Pandemic Influenza Vaccine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:

- AstraZeneca

- GlaxoSmithKline

- Novartis

- Sanofi

- Valneva

- Lupin

- Chiron Panacea

- Solvay and Serum Institute of India Pvt. Ltd.

- Sementis

Market size by Product

- Influenza A (H1N1) Vaccines

- Other

Market size by End User

- Adult

- Paediatric

Market size by Region

- North America

- - United States

- - Canada

- - Mexico

- Asia-Pacific

- - China

- - India

- - Japan

- - South Korea

- - Australia

- - Indonesia

- - Singapore

- - Malaysia

- - Philippines

- - Thailand

- - Vietnam

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Spain

- - Russia

- Central & South America

- - Brazil

- - Rest of Central & South America

- Middle East & Africa

- - GCC Countries

- - Turkey

- - Egypt

- - South Africa

The study objectives of this report are:

- To study and analyze the global Pandemic Influenza Vaccine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.

- To understand the structure of Pandemic Influenza Vaccine market by identifying its various subsegments.

- To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).

- Focuses on the key global Pandemic Influenza Vaccine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.

- To project the value and sales volume of Pandemic Influenza Vaccine submarkets, with respect to key regions.

- To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Pandemic Influenza Vaccine are as follows:

- History Year: 2014-2018

- Base Year: 2018

- Estimated Year: 2019

- Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Doses). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Pandemic Influenza Vaccine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Global Pandemic Influenza Vaccine Market Insights, Forecast to 2025

Table of Contents
1 Study Coverage
1.1 Pandemic Influenza Vaccine Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by Product
1.4.2 Influenza A (H1N1) Vaccines
1.4.3 Other
1.5 Market by End User
1.5.1 Global Pandemic Influenza Vaccine Market Size Growth Rate by End User
1.5.2 Adult
1.5.3 Paediatric
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Pandemic Influenza Vaccine Market Size
2.1.1 Global Pandemic Influenza Vaccine Revenue 2014-2025
2.1.2 Global Pandemic Influenza Vaccine Sales 2014-2025
2.2 Pandemic Influenza Vaccine Growth Rate by Regions
2.2.1 Global Pandemic Influenza Vaccine Sales by Regions
2.2.2 Global Pandemic Influenza Vaccine Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Pandemic Influenza Vaccine Sales by Manufacturers
3.1.1 Pandemic Influenza Vaccine Sales by Manufacturers
3.1.2 Pandemic Influenza Vaccine Sales Market Share by Manufacturers
3.1.3 Global Pandemic Influenza Vaccine Market Concentration Ratio (CR5 and HHI)
3.2 Pandemic Influenza Vaccine Revenue by Manufacturers
3.2.1 Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019)
3.2.2 Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
3.3 Pandemic Influenza Vaccine Price by Manufacturers
3.4 Pandemic Influenza Vaccine Manufacturing Base Distribution, Product Types
3.4.1 Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Pandemic Influenza Vaccine Product Type
3.4.3 Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Pandemic Influenza Vaccine Sales by Product
4.2 Global Pandemic Influenza Vaccine Revenue by Product
4.3 Pandemic Influenza Vaccine Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Pandemic Influenza Vaccine Breakdown Data by End User
6 North America
6.1 North America Pandemic Influenza Vaccine by Countries
6.1.1 North America Pandemic Influenza Vaccine Sales by Countries
6.1.2 North America Pandemic Influenza Vaccine Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Pandemic Influenza Vaccine by Product
6.3 North America Pandemic Influenza Vaccine by End User
7 Europe
7.1 Europe Pandemic Influenza Vaccine by Countries
7.1.1 Europe Pandemic Influenza Vaccine Sales by Countries
7.1.2 Europe Pandemic Influenza Vaccine Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Pandemic Influenza Vaccine by Product
7.3 Europe Pandemic Influenza Vaccine by End User
8 Asia Pacific
8.1 Asia Pacific Pandemic Influenza Vaccine by Countries
8.1.1 Asia Pacific Pandemic Influenza Vaccine Sales by Countries
8.1.2 Asia Pacific Pandemic Influenza Vaccine Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Pandemic Influenza Vaccine by Product
8.3 Asia Pacific Pandemic Influenza Vaccine by End User
9 Central & South America
9.1 Central & South America Pandemic Influenza Vaccine by Countries
9.1.1 Central & South America Pandemic Influenza Vaccine Sales by Countries
9.1.2 Central & South America Pandemic Influenza Vaccine Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Pandemic Influenza Vaccine by Product
9.3 Central & South America Pandemic Influenza Vaccine by End User
10 Middle East and Africa
10.1 Middle East and Africa Pandemic Influenza Vaccine by Countries
10.1.1 Middle East and Africa Pandemic Influenza Vaccine Sales by Countries
10.1.2 Middle East and Africa Pandemic Influenza Vaccine Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Pandemic Influenza Vaccine by Product
10.3 Middle East and Africa Pandemic Influenza Vaccine by End User
11 Company Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 Company Business Overview
11.1.3 AstraZeneca Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.1.4 AstraZeneca Pandemic Influenza Vaccine Products Offered
11.1.5 AstraZeneca Recent Development
11.2 GlaxoSmithKline
11.2.1 GlaxoSmithKline Company Details
11.2.2 Company Business Overview
11.2.3 GlaxoSmithKline Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.2.4 GlaxoSmithKline Pandemic Influenza Vaccine Products Offered
11.2.5 GlaxoSmithKline Recent Development
11.3 Novartis
11.3.1 Novartis Company Details
11.3.2 Company Business Overview
11.3.3 Novartis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Novartis Pandemic Influenza Vaccine Products Offered
11.3.5 Novartis Recent Development
11.4 Sanofi
11.4.1 Sanofi Company Details
11.4.2 Company Business Overview
11.4.3 Sanofi Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Sanofi Pandemic Influenza Vaccine Products Offered
11.4.5 Sanofi Recent Development
11.5 Valneva
11.5.1 Valneva Company Details
11.5.2 Company Business Overview
11.5.3 Valneva Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.5.4 Valneva Pandemic Influenza Vaccine Products Offered
11.5.5 Valneva Recent Development
11.6 Lupin
11.6.1 Lupin Company Details
11.6.2 Company Business Overview
11.6.3 Lupin Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.6.4 Lupin Pandemic Influenza Vaccine Products Offered
11.6.5 Lupin Recent Development
11.7 Chiron Panacea
11.7.1 Chiron Panacea Company Details
11.7.2 Company Business Overview
11.7.3 Chiron Panacea Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.7.4 Chiron Panacea Pandemic Influenza Vaccine Products Offered
11.7.5 Chiron Panacea Recent Development
11.8 Solvay and Serum Institute of India Pvt. Ltd.
11.8.1 Solvay and Serum Institute of India Pvt. Ltd. Company Details
11.8.2 Company Business Overview
11.8.3 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.8.4 Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Products Offered
11.8.5 Solvay and Serum Institute of India Pvt. Ltd. Recent Development
11.9 Sementis
11.9.1 Sementis Company Details
11.9.2 Company Business Overview
11.9.3 Sementis Pandemic Influenza Vaccine Sales, Revenue and Gross Margin (2014-2019)
11.9.4 Sementis Pandemic Influenza Vaccine Products Offered
11.9.5 Sementis Recent Development
12 Future Forecast
12.1 Pandemic Influenza Vaccine Market Forecast by Regions
12.1.1 Global Pandemic Influenza Vaccine Sales Forecast by Regions 2019-2025
12.1.2 Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2019-2025
12.2 Pandemic Influenza Vaccine Market Forecast by Product
12.2.1 Global Pandemic Influenza Vaccine Sales Forecast by Product 2019-2025
12.2.2 Global Pandemic Influenza Vaccine Revenue Forecast by Product 2019-2025
12.3 Pandemic Influenza Vaccine Market Forecast by End User
12.4 North America Pandemic Influenza Vaccine Forecast
12.5 Europe Pandemic Influenza Vaccine Forecast
12.6 Asia Pacific Pandemic Influenza Vaccine Forecast
12.7 Central & South America Pandemic Influenza Vaccine Forecast
12.8 Middle East and Africa Pandemic Influenza Vaccine Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Pandemic Influenza Vaccine Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Tables and Figures
Figure Pandemic Influenza Vaccine Product Picture
Table Pandemic Influenza Vaccine Market Segments
Table Key Manufacturers Pandemic Influenza Vaccine Covered
Table Global Pandemic Influenza Vaccine Market Size Growth Rate by Product 2019-2025 (K Doses) & (Million US$)
Figure Global Pandemic Influenza Vaccine Sales Market Share by Product 2014-2025
Figure Influenza A (H1N1) Vaccines Product Picture
Table Major Manufacturers of Influenza A (H1N1) Vaccines
Figure Other Product Picture
Table Major Manufacturers of Other
Table Global Pandemic Influenza Vaccine Market Size Growth Rate by End User 2019-2025 (K Doses)
Figure Adult
Figure Paediatric
Figure Pandemic Influenza Vaccine Report Years Considered
Figure Global Pandemic Influenza Vaccine Market Size 2014-2025 (Million US$)
Figure Global Pandemic Influenza Vaccine Sales 2014-2025 (K Doses)
Table Global Pandemic Influenza Vaccine Market Size by Regions 2014-2019 (K Doses) & (Million US$)
Table Global Pandemic Influenza Vaccine Sales by Regions 2014-2019 (K Doses)
Table Global Pandemic Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure Global Pandemic Influenza Vaccine Sales Market Share by Regions 2014-2019
Figure 2018 Global Pandemic Influenza Vaccine Sales Market Share by Regions
Table Global Pandemic Influenza Vaccine Revenue by Regions 2014-2019 (Million US$)
Table Global Pandemic Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure Global Pandemic Influenza Vaccine Revenue Market Share by Regions 2014-2019
Figure 2018 Global Pandemic Influenza Vaccine Revenue Market Share by Regions
Table Global Pandemic Influenza Vaccine Sales by Manufacturers (2014-2019) (K Doses)
Table Global Pandemic Influenza Vaccine Sales Share by Manufacturers (2014-2019)
Figure Global Pandemic Influenza Vaccine Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Pandemic Influenza Vaccine Revenue by Manufacturers (2014-2019) (Million USD)
Table Pandemic Influenza Vaccine Revenue Share by Manufacturers (2014-2019)
Figure Pandemic Influenza Vaccine Value Share by Manufacturers in 2018
Table Key Manufacturers Pandemic Influenza Vaccine Price (2014-2019) (USD/Dose)
Table Pandemic Influenza Vaccine Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Pandemic Influenza Vaccine Product Type
Table Date of International Manufacturers Enter into Pandemic Influenza Vaccine Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Global Pandemic Influenza Vaccine Sales Share by Product (2014-2019)
Figure Global Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure Global Pandemic Influenza Vaccine Sales Market Share by Product in 2018
Table Global Pandemic Influenza Vaccine Revenue by Product (2014-2019) (Million US$)
Table Global Pandemic Influenza Vaccine Revenue Share by Product (2014-2019)
Figure Global Pandemic Influenza Vaccine Revenue Market Share by Product (2014-2019)
Figure Global Pandemic Influenza Vaccine Revenue Market Share by Product in 2018
Table Pandemic Influenza Vaccine Price by Product 2014-2019 (USD/Dose)
Table Global Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Global Pandemic Influenza Vaccine Sales Share by End User (2014-2019)
Figure Global Sales Pandemic Influenza Vaccine Market Share by End User (2014-2019)
Figure Global Sales Pandemic Influenza Vaccine Market Share by End User in 2018
Figure North America Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure North America Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table North America Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table North America Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 North America Pandemic Influenza Vaccine Sales Market Share by Countries
Table North America Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table North America Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Pandemic Influenza Vaccine Revenue Market Share by Countries
Figure United States Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure United States Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (K Doses)
Figure Canada Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Canada Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Mexico Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table North America Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table North America Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 North America Pandemic Influenza Vaccine Market Share by Product
Table North America Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table North America Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 North America Pandemic Influenza Vaccine Market Share by End User
Figure Europe Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Europe Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Europe Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Pandemic Influenza Vaccine Sales Market Share by Countries
Table Europe Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Europe Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Pandemic Influenza Vaccine Revenue Market Share by Countries
Figure Germany Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Germany Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure France Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure France Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure UK Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Italy Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Russia Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Europe Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Europe Pandemic Influenza Vaccine Market Share by Product
Table Europe Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Europe Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Europe Pandemic Influenza Vaccine Market Share by End User
Figure Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Countries
Table Asia Pacific Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Pandemic Influenza Vaccine Revenue Market Share by Countries
Figure China Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure China Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Japan Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Korea Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure India Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure India Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Australia Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Indonesia Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Malaysia Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Philippines Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Thailand Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Vietnam Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Singapore Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Asia Pacific Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Pandemic Influenza Vaccine Market Share by Product
Table Asia Pacific Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Asia Pacific Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Pandemic Influenza Vaccine Market Share by End User
Figure Central & South America Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Central & South America Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Central & South America Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pandemic Influenza Vaccine Sales Market Share by Countries
Table Central & South America Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Pandemic Influenza Vaccine Revenue Market Share by Countries
Figure Brazil Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Brazil Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Argentina Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Central & South America Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Pandemic Influenza Vaccine Market Share by Product
Table Central & South America Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Central & South America Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Pandemic Influenza Vaccine Market Share by End User
Figure Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate 2014-2019 (K Doses)
Figure Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Pandemic Influenza Vaccine Sales by Countries (2014-2019) (K Doses)
Table Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Countries
Table Middle East and Africa Pandemic Influenza Vaccine Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Pandemic Influenza Vaccine Revenue Market Share by Countries
Figure GCC Countries Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure GCC Countries Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Turkey Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure Egypt Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Pandemic Influenza Vaccine Sales Growth Rate (2014-2019) (K Doses)
Figure South Africa Pandemic Influenza Vaccine Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Pandemic Influenza Vaccine Sales by Product (2014-2019) (K Doses)
Table Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Pandemic Influenza Vaccine Market Share by Product
Table Middle East and Africa Pandemic Influenza Vaccine Sales by End User (2014-2019) (K Doses)
Table Middle East and Africa Pandemic Influenza Vaccine Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Pandemic Influenza Vaccine Market Share by End User
Table AstraZeneca Company Details
Table AstraZeneca Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table AstraZeneca Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Novartis Recent Development
Table Sanofi Company Details
Table Sanofi Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sanofi Recent Development
Table Valneva Company Details
Table Valneva Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Valneva Recent Development
Table Lupin Company Details
Table Lupin Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Lupin Recent Development
Table Chiron Panacea Company Details
Table Chiron Panacea Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Chiron Panacea Recent Development
Table Solvay and Serum Institute of India Pvt. Ltd. Company Details
Table Solvay and Serum Institute of India Pvt. Ltd. Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Solvay and Serum Institute of India Pvt. Ltd. Recent Development
Table Sementis Company Details
Table Sementis Pandemic Influenza Vaccine Sales (K Doses), Revenue (Million USD), Price (USD/Dose) and Gross Margin (2014-2019)
Table Sementis Recent Development
Table Global Pandemic Influenza Vaccine Sales Forecast by Regions 2019-2025 (K Doses)
Table Global Pandemic Influenza Vaccine Sales Market Share Forecast by Regions 2019-2025
Table Global Pandemic Influenza Vaccine Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Regions 2019-2025
Table Global Pandemic Influenza Vaccine Sales Forecast by Product 2019-2025 (K Doses)
Table Global Pandemic Influenza Vaccine Sales Market Share Forecast by Product 2019-2025
Table Global Pandemic Influenza Vaccine Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Pandemic Influenza Vaccine Revenue Market Share Forecast by Product 2019-2025
Table Global Pandemic Influenza Vaccine Sales Forecast by End User 2019-2025 (K Doses)
Table Global Pandemic Influenza Vaccine Sales Market Share Forecast by End User 2019-2025
Figure North America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure North America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Pandemic Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Europe Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Pandemic Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Asia Pacific Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Pandemic Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Central & South America Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Pandemic Influenza Vaccine Sales Growth Rate Forecast (2019-2025) (K Doses)
Figure Middle East and Africa Pandemic Influenza Vaccine Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Pandemic Influenza Vaccine Value Chain
Table Pandemic Influenza Vaccine Customers List
Table Pandemic Influenza Vaccine Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
  • Global Recombinant Human Erythropoietin (rhEPO) Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 99
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ESRD - Cancer - HIV - Wounds and Neural Disease Segment by Application - Hospi......
  • Global rhEPO Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 97
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - ESRD - Cancer - HIV - Wounds and neural disease Segment by Application - Hospi......
  • Global Rhematoid Arthritis Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 94
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Pharmaceuticals - Biopharmaceuticals Segment by Application - Prescription - OTC......
  • Global Chronic Obstructive Pulmonary Disease Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 118
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Inhalers - Nebulizers Segment by Application - Emphysema - Chronic Bronchitis ......
  • Global Chronic Lymphocytic Leukemia Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 121
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Acutemyeloid (ormyelogenous)leukemia (AML) - Chronicmyeloid (ormyelogenous)leukemia (CML) - Acutelymphocyti......
  • Global Chemotherapy-induced Nausea and Vomiting Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 93
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - 5-HT3 Inhibitors - NK1 Inhibitors - Other Segment by Application - Highly Emetogenic ......
  • Global Chemotheraphy Induced Nausea and Vomitting (CINV) Drugs Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 120
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Aloxi (Palonosetron) - Kytril Generic (Granisetron) - Emend (Aprepitant) - Akynzeo (Netupitant-Palon......
  • Global ß-blockers Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 122
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Nonselective Agents - Selective Agents Segment by Application - Abnormal Heart Rhythms......
  • Global a-adrenoreceptor Antagonists Market Research Report 2021
    Published: 15-Jan-2021        Price: US 2900 Onwards        Pages: 116
    The research report includes specific segments by region (country), by company, by Type and by Application. This study provides information about the sales and revenue during the historic and forecasted period of 2016 to 2027. Understanding the segments helps in identifying the importance of different factors that aid the market growth. Segment by Type - Non-selective Antagonists - Selective Antagonists Segment by Application - Hypertension......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs